Author(s): S. R Suseem, Dhanish Joseph

Email(s): dhanishjoseph707@gmail.com

DOI: 10.5958/0974-360X.2019.00067.2   

Address: Dr S. R Suseem1, Dhanish Joseph2*
1Assistant Professor, School of Advanced Sciences, VIT, Vellore
2PhD Scholar, School of Advanced Sciences, VIT, Vellore
*Corresponding Author

Published In:   Volume - 12,      Issue - 1,     Year - 2019


ABSTRACT:
Naringin and naringenin are the two common flavonoids present in the citrus fruits especially in grapefruit. Both this does wonderful functions in human body. It is being contraindicated with many of the drug products due to extensive variation in the kinetics of drugs when both dug and this flavonoid administered together. Thus all the doctors counsel the patients not to have grape fruit with many of the drugs. The common people or the patients are much worried in taking the citrus fruit even after completion of the treatment because of certain myth behind this. The current study aims to reveal the reality behind this caption. The review conducted confirms various proven therapeutic activities of naringin and naringenin as a supplement and certain synergistic effects. It is proven that the consumption of either grape fruit or as naringin or naringenin itself keeps the body healthy away from various illnesses. And it is highly active against various major life style disorders and even as an anti-neoplastic agent.


Cite this article:
S. R Suseem, Dhanish Joseph. The Myth and The fact on Naringin –A Review. Research J. Pharm. and Tech 2019; 12(1): 367-374. doi: 10.5958/0974-360X.2019.00067.2

Cite(Electronic):
S. R Suseem, Dhanish Joseph. The Myth and The fact on Naringin –A Review. Research J. Pharm. and Tech 2019; 12(1): 367-374. doi: 10.5958/0974-360X.2019.00067.2   Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-1-67


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available